Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
SARATOGA, Calif. & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF) and Gencia Corporation today announced a collaboration to advance myelin repair therapeutic development for Multiple Sclerosis (MS). Through its unique Accelerated Research Collaboration™ (ARC™) model, the Myelin Repair Foundation will partner with Gencia Corporation to assess the myelin regenerating capabilities of the company’s proprietary therapeutic compounds for MS.
Help employers find you! Check out all the jobs and post your resume.
SARATOGA, Calif. & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--The Myelin Repair Foundation (MRF) and Gencia Corporation today announced a collaboration to advance myelin repair therapeutic development for Multiple Sclerosis (MS). Through its unique Accelerated Research Collaboration™ (ARC™) model, the Myelin Repair Foundation will partner with Gencia Corporation to assess the myelin regenerating capabilities of the company’s proprietary therapeutic compounds for MS.
Help employers find you! Check out all the jobs and post your resume.
